336 related articles for article (PubMed ID: 24009284)
1. Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
Békássy ZD; Kristoffersson AC; Cronqvist M; Roumenina LT; Rybkine T; Vergoz L; Hue C; Fremeaux-Bacchi V; Karpman D
Nephrol Dial Transplant; 2013 Nov; 28(11):2899-907. PubMed ID: 24009284
[TBL] [Abstract][Full Text] [Related]
2. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
Okumi M; Tanabe K
Nephrology (Carlton); 2016 Jul; 21 Suppl 1():9-13. PubMed ID: 26988663
[TBL] [Abstract][Full Text] [Related]
3. Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.
Gilbert RD; Fowler DJ; Angus E; Hardy SA; Stanley L; Goodship TH
Pediatr Nephrol; 2013 Aug; 28(8):1315-8. PubMed ID: 23624872
[TBL] [Abstract][Full Text] [Related]
4. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
[TBL] [Abstract][Full Text] [Related]
5. Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.
Wehling C; Amon O; Bommer M; Hoppe B; Kentouche K; Schalk G; Weimer R; Wiesener M; Hohenstein B; Tönshoff B; Büscher R; Fehrenbach H; Gök ÖN; Kirschfink M
Clin Exp Immunol; 2017 Feb; 187(2):304-315. PubMed ID: 27784126
[TBL] [Abstract][Full Text] [Related]
6. Tailored eculizumab therapy in the management of complement factor H-mediated atypical hemolytic uremic syndrome in an adult kidney transplant recipient: a case report.
Xie L; Nester CM; Reed AI; Zhang Y; Smith RJ; Thomas CP
Transplant Proc; 2012 Dec; 44(10):3037-40. PubMed ID: 23195022
[TBL] [Abstract][Full Text] [Related]
7. A patient with a homozygous diacylglycerol kinase epsilon (DGKE) gene mutation with atypical haemolytic uraemic syndrome and low C3 responded well to eculizumab: a case report.
Alabdulqader M; Alfakeeh K
BMC Nephrol; 2021 Apr; 22(1):140. PubMed ID: 33879077
[TBL] [Abstract][Full Text] [Related]
8. Use of eculizumab and plasma exchange in successful combined liver-kidney transplantation in a case of atypical HUS associated with complement factor H mutation.
Tran H; Chaudhuri A; Concepcion W; Grimm PC
Pediatr Nephrol; 2014 Mar; 29(3):477-80. PubMed ID: 24221349
[TBL] [Abstract][Full Text] [Related]
9. Eculizumab in the treatment of atypical haemolytic uraemic syndrome and other complement-mediated renal diseases.
Nester CM; Brophy PD
Curr Opin Pediatr; 2013 Apr; 25(2):225-31. PubMed ID: 23486421
[TBL] [Abstract][Full Text] [Related]
10. Eculizumab in anti-factor h antibodies associated with atypical hemolytic uremic syndrome.
Diamante Chiodini B; Davin JC; Corazza F; Khaldi K; Dahan K; Ismaili K; Adams B
Pediatrics; 2014 Jun; 133(6):e1764-8. PubMed ID: 24843055
[TBL] [Abstract][Full Text] [Related]
11. Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.
Zuber J; Le Quintrec M; Krid S; Bertoye C; Gueutin V; Lahoche A; Heyne N; Ardissino G; Chatelet V; Noël LH; Hourmant M; Niaudet P; Frémeaux-Bacchi V; Rondeau E; Legendre C; Loirat C;
Am J Transplant; 2012 Dec; 12(12):3337-54. PubMed ID: 22958221
[TBL] [Abstract][Full Text] [Related]
12. Midterm Outcomes of 12 Renal Transplant Recipients Treated With Eculizumab to Prevent Atypical Hemolytic Syndrome Recurrence.
Levi C; Frémeaux-Bacchi V; Zuber J; Rabant M; Devriese M; Snanoudj R; Scemla A; Amrouche L; Mejean A; Legendre C; Sberro-Soussan R
Transplantation; 2017 Dec; 101(12):2924-2930. PubMed ID: 28858176
[TBL] [Abstract][Full Text] [Related]
13. Rare genetic variant in the CFB gene presenting as atypical hemolytic uremic syndrome and immune complex diffuse membranoproliferative glomerulonephritis, with crescents, successfully treated with eculizumab.
Alfakeeh K; Azar M; Alfadhel M; Abdullah AM; Aloudah N; Alsaad KO
Pediatr Nephrol; 2017 May; 32(5):885-891. PubMed ID: 28210841
[TBL] [Abstract][Full Text] [Related]
14. Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies.
Zuber J; Fakhouri F; Roumenina LT; Loirat C; Frémeaux-Bacchi V;
Nat Rev Nephrol; 2012 Nov; 8(11):643-57. PubMed ID: 23026949
[TBL] [Abstract][Full Text] [Related]
15. Atypical haemolytic uraemic syndrome treated with the complement inhibitor eculizumab: the experience of the Australian compassionate access cohort.
Mallett A; Hughes P; Szer J; Tuckfield A; Van Eps C; Cambell SB; Hawley C; Burke J; Kausman J; Hewitt I; Parnham A; Ford S; Isbel N
Intern Med J; 2015 Oct; 45(10):1054-65. PubMed ID: 26247170
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Eculizumab Therapy for Atypical Hemolytic Uremic Syndrome Recurrence and Antibody-Mediated Rejection Progress After Renal Transplantation With Preformed Donor-Specific Antibodies: Case Report.
Yamamoto T; Watarai Y; Futamura K; Okada M; Tsujita M; Hiramitsu T; Goto N; Narumi S; Takeda A; Kobayashi T
Transplant Proc; 2017; 49(1):159-162. PubMed ID: 28104125
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic eculizumab for kidney transplantation in a child with atypical hemolytic uremic syndrome due to complement factor H mutation.
Ranch D; Crowther B; Arar M; Assanasen C
Pediatr Transplant; 2014 Sep; 18(6):E185-9. PubMed ID: 24931815
[TBL] [Abstract][Full Text] [Related]
18. Liver transplantation for aHUS: still needed in the eculizumab era?
Coppo R; Bonaudo R; Peruzzi RL; Amore A; Brunati A; Romagnoli R; Salizzoni M; Galbusera M; Gotti E; Daina E; Noris M; Remuzzi G
Pediatr Nephrol; 2016 May; 31(5):759-68. PubMed ID: 26604087
[TBL] [Abstract][Full Text] [Related]
19. Atypical hemolytic uremic syndrome: Review of clinical presentation, diagnosis and management.
Sridharan M; Go RS; Willrich MAV
J Immunol Methods; 2018 Oct; 461():15-22. PubMed ID: 30031798
[TBL] [Abstract][Full Text] [Related]
20. Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.
Besbas N; Gulhan B; Karpman D; Topaloglu R; Duzova A; Korkmaz E; Ozaltin F
Pediatr Nephrol; 2013 Jan; 28(1):155-8. PubMed ID: 22956028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
